Management of adult patients with perioperative pulmonary hypertension: Technical aspects and therapeutic options

Cardiology

Volumn 116, Issue 1, 2010, Pages 3-9

  Winterhalter, Michael ^a   Antoniou, Theofani ^c   Loukanov, Tsvetomir ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c ONASSIS CARDIAC SURGERY CENTER   (Greece)

Author keywords

Cardiac surgery; Cardiopulmonary bypass; Iloprost; Inhalation; Perioperative management; Pulmonary hypertension

Indexed keywords

DOBUTAMINE; GLYCERYL TRINITRATE; HEPARIN; ILOPROST; MILRINONE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; NORADRENALIN; PROSTACYCLIN; PROSTAGLANDIN E1; PROTAMINE; VASODILATOR AGENT;

CARDIOPULMONARY BYPASS; CLINICAL TRIAL; DISEASE EXACERBATION; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG WITHDRAWAL; ENDARTERECTOMY; HEART AFTERLOAD; HEART OUTPUT; HEART RIGHT VENTRICLE FAILURE; HEART SURGERY; HEART TRANSPLANTATION; HEART VENTRICLE CONTRACTILITY; HIGH RISK PATIENT; HUMAN; HYPOTENSION; INTRAOPERATIVE PERIOD; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MITRAL VALVE STENOSIS; MORTALITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; RISK FACTOR; UNSPECIFIED SIDE EFFECT;

ADULT; CARDIAC SURGICAL PROCEDURES; HEART DISEASES; HUMANS; HYPERTENSION, PULMONARY; ILOPROST; NITRIC OXIDE; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; VASODILATOR AGENTS;

EID: 77951248351     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000313863     Document Type: Review

References (25)

1. Roques F, Nashef SAM, Michel P, et al: Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19,030 patients. Eur J Cardiothorac Surg 1999; 15: 816-822.
2. Galiè N, Hoeper MM, Humbert M, et al: Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009; 30: 2493-2537.
3. Kaul TK, Fields BL: Postoperative acute refractory right ventricular failure: incidence, pathogenesis, management and prognosis. Cardiovasc Surg 2000; 8: 1-9.
4. Naik SK, Knight A, Elliott M: A prospective randomized study of a modified technique of ultrafiltration during pediatric open-heart surgery. Circulation 1991; 84(5 suppl):III422- III431.
5. Vlahakes GJ: Management of pulmonary hypertension and right ventricular failure: another step forward. Ann Thorac Surg 1996; 61: 1051-1052.
6. Griffin MJ, Hines RL: Management of perioperative ventricular dysfunction. J Cardiothorac Vasc Anesth 2001; 15: 90-106.
7. Fischer LG, Van Aken H, Burkle H: Management of pulmonary hypertension. Anesth Analg 2003; 96: 1603-1616.
8. Walmrath D, Olschewski H, Grimminger F, et al: NO and alternative inhalational therapy approaches in pulmonary hypertension. Internist 1997; 38: 453-460.
9. Solina A, Papp D, Ginsberg S, et al: A comparison of inhaled nitric oxide and milrinone for the treatment of pulmonary hypertension in adult cardiac surgery patients. J Cardiothorac Vasc Anesth 2000; 14: 12-17.
10. Schmid ER, Bürki C, Engel MH, et al: Inhaled nitric oxide versus intravenous vasodilators in severe pulmonary hypertension after cardiac surgery. Anesth Analg 1999; 89: 1108-1115.
11. Fullerton DA, Jones SD, Jaggers J, et al: Effective control of pulmonary vascular resistance with inhaled nitric oxide after cardiac operation. J Thorac Cardiovasc Surg 1996; 111: 753-762; discussion 762-763.
12. Germann P, Braschi A, Della Rocca G, et al: Inhaled nitric oxide therapy in adults: European expert recommendations. Intensive Care Med 2005; 31: 1029-1041.
13. Kieler-Jensen N, Milocco I, Ricksten SE: Pulmonary vasodilation after heart transplantation: a comparison among prostacyclin, sodium nitroprusside, and nitroglycerin on right ventricular function and pulmonary selectivity. J Heart Lung Transplant 1993; 12: 179-184. (Pubitemid 23123857)
14. Rajek A, Pernerstorfer T, Kastner J, et al: Inhaled nitric oxide reduces pulmonary vascular resistance more than prostaglandin E1 during heart transplantation. Anesth Analg 2000; 90: 523-530.
15. Ardehali A, Hughes K, Sadeghi A, et al: Inhaled nitric oxide for pulmonary hypertension after heart transplantation. Transplantation 2001; 72: 638-641. (Pubitemid 32802745)
16. Lamarche Y, Perrault LP, Maltais S, et al: Preliminary experience with inhaled milrinone in cardiac surgery. Eur J Cardiothorac Surg 2007; 31: 1081-1087.
17. Theodoraki K, Rellia P, Thanopoulos A, et al: Inhaled iloprost controls pulmonary hypertension after cardiopulmonary bypass. Can J Anesth 2002; 49: 963-967.
18. Theodoraki K, Tsiapras D, Tsourelis L, et al: Inhaled iloprost in eight heart transplant recipients presenting with post-bypass acute right ventricular dysfunction. Acta Anaesthesiol Scand 2006; 50: 1213-1217.
19. Fattouch K, Sbraga F, Bianco G, et al: Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement. J Card Surg 2005; 20: 171-176.
20. Rex S, Schaelte G, Metzelder S, et al: Inhaled iloprost to control pulmonary artery hypertension in patients undergoing mitral valve surgery: a prospective, randomized controlled trial. Acta Anesthesiol Scand 2008; 52: 65-72.
21. Kramm T, Eberle B, Krummenauer F, et al: Inhaled iloprost in patients with chronic thromboembolic pulmonary hypertension: effects before and after pulmonary thromboendarterectomy. Ann Thorac Surg 2003; 76: 711-718. (Pubitemid 37100727)
22. Kramm T, Eberle B, Guth S, et al: Inhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomy. Eur J Cardiothorac Surg 2005; 28: 882-888.
23. Winterhalter M, Simon A, Fischer S, et al: Comparison of inhaled iloprost and nitric oxide in patients with pulmonary hypertension during weaning from cardiopulmonary bypass in cardiac surgery: a prospective randomized trial. J Cardiothorac Vasc Anesth 2008; 3: 406-413.
24. Winterhalter M, Fischer S, Tessmann R, et al: Using inhaled iloprost to wean from cardiopulmonary bypass after implanting a left ventricular assist device. Anesth Analg 2006; 103: 515-516.
25. Winterhalter M, Simon A, Fischer S, et al: Inhaled iloprost in lung transplantation: can it avoid extracorporeal circulation in patients with severe pulmonary hypertension? J Cardiothorac Vasc Anesth 2006; 20: 716-718.